Application of Transfection Reagents in In Vitro Diagnostics and mRNA Research

Common Uses of Transfection Reagents in IVD R&D

In IVD reagent R&D, transfection reagents are commonly used to construct recombinant cell lines, express specific antigens or antibodies, and establish reporter gene-based functional assay models. For example, in the detection of autoantibody-related antibodies, transfection can be used to make cells express specific autoantigens for establishing immunofluorescence or chemiluminescence detection systems. The requirements for transfection reagents in such applications typically include low toxicity to production cell lines, stable expression levels, and acceptable cost.

When constructing stably expressing cell lines, a strategy of plasmid transfection followed by selective pressure screening is often used. Transfection reagents need to ensure a certain transfection efficiency while minimizing the impact on cell viability, so as to improve monoclonal formation rate and subsequent screening efficiency. For suspension-adapted cells, choosing reagents that support suspension transfection is more critical.

mRNA Delivery and Emerging Detection Technologies

In recent years, mRNA technology has attracted attention in the vaccine and therapeutic fields, and transfection reagents have also been applied in mRNA delivery research. Compared with plasmids, mRNA does not need to enter the nucleus and expresses rapidly after transfection, but mRNA itself is prone to degradation and places higher demands on the delivery system. Some transfection reagents have been optimized for mRNA and can efficiently deliver mRNA in vitro to immune cells, tumor cells, or other target cells.

mRNA modification: The use of modified nucleotides can reduce innate immune responses and improve expression stability.

Cell type: Different immune cells have different tolerance to transfection reagents, and gradient experiments are required.

Expression time course: After mRNA transfection, expression usually begins within several hours, making it suitable for short-term functional studies.

Combined applications: In organoids or primary cells, mRNA delivery can be used for gene function validation or cell reprogramming research.

Considerations for Transfection of Organoids and Primary Cells

Organoids and primary cells are increasingly used in IVD and disease models, but their transfection difficulty is usually higher than that of conventional cell lines. Transfection reagents need to achieve nucleic acid delivery while maintaining the three-dimensional structure of the cells. It is generally recommended to perform transfection after dissociating organoids into single cells and then allowing them to reaggregate, or to use auxiliary methods such as microfluidics or electroporation. After transfection, attention should be paid to cell viability and marker expression to avoid false-negative results caused by reagent toxicity.

When developing diagnostic models based on primary cells, transfection conditions need to be compatible with batch-to-batch differences in clinical samples. Differences among cell donors may affect transfection efficiency, so establishing robust positive and negative controls is particularly important.

General Principles for Selection and Optimization

Whether used for IVD R&D or mRNA delivery research, the selection of transfection reagents should be based on the cell model, nucleic acid type, downstream detection method, and scalability. It is recommended to compare two to three transfection reagents with different mechanisms at an early stage and record data on cell viability, transfection efficiency, and batch-to-batch stability. The use of endotoxin-free nucleic acids and optimized culture media can also help improve experimental reproducibility.

With the progress of IVD and nucleic acid drug R&D, as a basic tool, the performance evaluation of transfection reagents will place greater emphasis on cell specificity, safety, and process compatibility, and related research is expected to promote the emergence of more efficient and gentler delivery systems.